eXoZymes Inc. (EXOZ) vs Xilio Therapeutics, Inc. (XLO)

eXoZymes Inc. and Xilio Therapeutics, Inc. are both Biotechnology companies. eXoZymes Inc. and Xilio Therapeutics, Inc. are of similar size ($59.2M and $57.6M). eXoZymes Inc. has the higher net margin (0.00% vs −34.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Xilio Therapeutics, Inc. leads on 7 and eXoZymes Inc. on 5.

Valuation

Metric EXOZ XLO Biotechnology median
P/E n/m n/m 7.88
P/S n/m 2.74 11.47
P/B 14.81 2.43 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 0.75 10.73
Earnings yield (19.04%) (16.49%) (28.84%)
Free cash flow yield (13.19%) (34.93%) (23.03%)

Profitability

Metric EXOZ XLO Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (48.94%) 0.00%
Net margin 0.00% (34.06%) 0.00%
Free cash flow margin 0.00% (95.59%) 0.00%
Return on equity (187.16%) (55.03%) (57.72%)
Return on assets (115.42%) (15.16%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EXOZ XLO Biotechnology median
Revenue growth (TTM) — 327.25% 5.64%
EPS growth (last fiscal year) (22.47%) 72.55% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EXOZ XLO Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 3.81 4.25 4.73
Net debt to EBITDA 0.31 3.40 0.96

Dividend

Metric EXOZ XLO Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric EXOZ XLO Biotechnology median
Market cap 57.55m 59.22m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack